Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

NRT Smoking Cessation Aids in

NRT Smoking Cessation Aids in Australia

19 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Changes in taxation for tobacco products benefit NRT smoking cessation aids

Sales of NRT smoking cessation aids continued to increase in 2018, supported by more stringent regulations on smoking and tobacco control and rising tobacco taxes, which have created incentives for smokers to quit their tobacco habits. In fact, the taxation on tobacco was increased again in September 2017 as the Australian Government announced an amendment to the taxation of fine cut tobacco products (referred to as roll your own tobacco) and other tobacco products such as cigars, bringing these rates in line with those of manufactured cigarettes.

The jury remains out as to whether vapour devices pose a threat to NRT

Electronic cigarettes continue to gain traction in Australia despite legal barriers and the category increasingly poses a threat to sales of NRT smoking cessation aids. Vapour products and e-liquids containing nicotine are prohibited in Australia.

Slower growth expected to be seen during the forecast period

During the forecast period, it is expected that a smaller proportion of young Australians will take up smoking compared with previous generations and this is due to the high unit prices of tobacco and the government’s plain packaging legislation. As smoking prevalence continues to fall, growth in NRT smoking cessation aids is likely to slow as fewer consumers require products that can help them to quit smoking.

COMPETITIVE LANDSCAPE

Nicorette and Nicabate remain the leading brands, underlining the dominance of major international players

International players dominate sales in NRT smoking cessation aids and the presence of local companies remains minimal. Johnson & Johnson Pacific Pty Ltd remained the leading player in 2018 with its very popular brand Nicorette, followed by GSK Consumer Healthcare with Nicabate.

Perrigo Australia launches Nicotinell therapy pack

The main innovation in the category in 2018 was Perrigo Australia’s launch of the first combination therapy NRT product, which includes patch and gum under the Nicotinell brand. Although the individual products that comprise the pack are not new per se, there is a novelty factor in offering the gum and patch in a bundle as a therapy pack.

Files are delivered directly into your account within a few minutes of purchase.

Samples

NRT Smoking Cessation Aids Sample Report NRT Smoking Cessation Aids Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in Australia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the NRT Smoking Cessation Aids industry in Australia, our research will save you time and money while empowering you to make informed, profitable decisions.

The NRT Smoking Cessation Aids in Australia market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Production, imports by origin, exports by destination
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of NRT Smoking Cessation Aids in Australia?
What are the major brands in Australia?
How have tobacco bans affected the sales of NRT Smoking Cessation Aids?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

NRT Smoking Cessation Aids in Australia - Category analysis

HEADLINES

PROSPECTS

Changes in taxation for tobacco products benefit NRT smoking cessation aids

The jury remains out as to whether vapour devices pose a threat to NRT

Slower growth expected to be seen during the forecast period

COMPETITIVE LANDSCAPE

Nicorette and Nicabate remain the leading brands, underlining the dominance of major international players

Perrigo Australia launches Nicotinell therapy pack

CATEGORY INDICATORS

Table 1 Number of Smokers by Gender 2013-2018

CATEGORY DATA

Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018
Table 4 Sales of NRT Gum by Flavour: % Value 2013-2018
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023

Consumer Health in Australia - Industry Overview

EXECUTIVE SUMMARY

Regulation and shifting demand for vitamins and dietary supplement define industry

Consumer health products remain popular in Australia but sales slow down

Acquisitions of local companies continue

Distribution continues to evolve as the presence of discount pharmacies increases

The trend towards self-care management set to support consumer health sales

MARKET INDICATORS

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format: % Value 2013-2018
Table 17 Distribution of Consumer Health by Format and Category: % Value 2018
Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

NRT Smoking Cessation Aids in Australia

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Changes in taxation for tobacco products benefit NRT smoking cessation aids

The jury remains out as to whether vapour devices pose a threat to NRT

Slower growth expected to be seen during the forecast period

COMPETITIVE LANDSCAPE

Nicorette and Nicabate remain the leading brands, underlining the dominance of major international players

Perrigo Australia launches Nicotinell therapy pack

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

NRT Smoking Cessation Aids in Australia - Category analysis

HEADLINES

PROSPECTS

Changes in taxation for tobacco products benefit NRT smoking cessation aids

The jury remains out as to whether vapour devices pose a threat to NRT

Slower growth expected to be seen during the forecast period

COMPETITIVE LANDSCAPE

Nicorette and Nicabate remain the leading brands, underlining the dominance of major international players

Perrigo Australia launches Nicotinell therapy pack

CATEGORY INDICATORS

CATEGORY DATA

Consumer Health in Australia - Industry Overview

EXECUTIVE SUMMARY

Regulation and shifting demand for vitamins and dietary supplement define industry

Consumer health products remain popular in Australia but sales slow down

Acquisitions of local companies continue

Distribution continues to evolve as the presence of discount pharmacies increases

The trend towards self-care management set to support consumer health sales

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports